Analyst Price Target is $7.00
▲ +81.35% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for SELLAS Life Sciences Group in the last 3 months. The average price target is $7.00, with a high forecast of $8.00 and a low forecast of $6.00. The average price target represents a 81.35% upside from the last price of $3.86.
Current Consensus is
The current consensus among 2 investment analysts is to buy stock in SELLAS Life Sciences Group.